Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) Operating Expenses (2016 - 2025)

Bio Key International (BKYI) has disclosed Operating Expenses for 16 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • Quarterly Operating Expenses fell 7.8% to $2.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Sep 2025, down 9.94% year-over-year, with the annual reading at $9.7 million for FY2024, 5.91% down from the prior year.
  • Operating Expenses hit $2.1 million in Q3 2025 for Bio Key International, down from $2.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $5.8 million in Q4 2022 to a low of $1.9 million in Q2 2021.
  • Historically, Operating Expenses has averaged $2.6 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Operating Expenses: soared 125.2% in 2022 and later tumbled 54.45% in 2023.
  • Year by year, Operating Expenses stood at $2.6 million in 2021, then skyrocketed by 125.2% to $5.8 million in 2022, then plummeted by 54.45% to $2.6 million in 2023, then dropped by 6.12% to $2.5 million in 2024, then decreased by 15.55% to $2.1 million in 2025.
  • Business Quant data shows Operating Expenses for BKYI at $2.1 million in Q3 2025, $2.3 million in Q2 2025, and $2.0 million in Q1 2025.